Hilltelligence markHilltelligence
Archived This bill is from the 118th Congress (2023–2024) and is no longer under active consideration.
Bills/H.R. 2297118th Congress

To provide for a limitation on availability of funds for Related Agency and Food and Drug Administration, FDA Innovation Account, Cures Act for fiscal year 2024.

House: Referred
Cosponsors
2
Introduced
2023-03-29
Last action
2023-04-07

Referred to the Subcommittee on Health.

Sign in to view Hilltelligence’s plain-English summary.

Action Timeline
  1. HouseLatest

    Referred to the Subcommittee on Health.

  2. House

    Referred to the House Committee on Energy and Commerce.

  3. House

    Introduced in House

Sign in to view Hilltelligence’s passage-probability analysis.

Official Sources
Topics

Policy area

Health

Sign in to view Hilltelligence’s potential-cosponsor analysis.